Abstract. Among 28 menstruating women tested once randomly during the cycle, somatomedin-C (Sm-C) values were lower in the 10 women in normal follicular phase than in the 10 women in normal luteal phase or the 8 women with hyperandrogenism. Among these 28 subjects, Sm-C showed a positive correlation with testosterone and a positive correlation of borderline significance with oestradiol. A positive correlation was also evidenced between Sm-C and In progesterone among the 20 women of this group who were not hyperandrogenic. In 5 other normal women investigated daily throughout an entire menstrual cycle, Sm-C concentrations were higher during days +4 to +9 of this cycle (luteal phase) than during days \m=-\3to \m=-\8(follicular phase). In another group of 21 healthy women, Sm-C values were increased during medroxyprogesterone acetate (150 mg trimestrially) treatment. In 7 normal men, Sm-C decreased during ethinyl-oestradiol (1 mg daily for 5 days) administration. These findings suggest that circulating Sm-C levels are modulated by variations of sex steroids which occur during the menstrual cycle as well as by pharmacological doses of oestrogens and progestagens.
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The effects of sex steroids on serum somatomedin (Sm-C) concentrations are still controversial. It has been previously reported that administration of high doses of ethinyl-oestradiol decreased cir¬ culating Sm-C concentrations in acromegaly (Clemmons et al. 1980 (Rosenfield et al. 1983) . Similarly, intramuscular testosterone therapy has been shown to increase Sm-C levels in GH-sufficient prepubertal males (Parker et al. 1984 ). However, in adults intramuscular testoster¬ one in pharmacological doses had no significant effect on Sm-C, while medroxyprogesterone ace¬ tate was found to increase Sm-C levels (Meyer et al. 1982 (Robyn et al. 1971 ), FSH (Odell & Hescox 1971) , oestradiol, progesterone (Delvoye et al. 1978) , testosterone (Delbeke & Lejeune-Lenain 1982) were measured by previously described radioimmunoassays.
Normal follicular progesterone values are <0.8 ng/ml; normal testosterone values are < 0.6 ng/ml. Sm-C was measured on non-acidified, unextracted serum using a modification of a previously described method (Furlanetto et al. 1977 . This modified assay is per¬ formed in polyethylene tubes and the assay buffer contains 0.5 U/ml sodium heparin. All serum samples were assayed in duplicate at two dilutions and samples from the same subject were analyzed in a single assay. The intra-and inter-assay coefficients of variation aver¬ aged 10 and 19%, respectively. A pool of sera from 20 normal adult subjects (arbitrarily considered to contain 1 U/ml) was used as standard. The normal range for adults in the assay is 0.4-1.5 U/ml. A weak positive correlation (r = 0.37, = 0.05) was found between Sm-C and oestradiol only when all three groups were considered together. Sm-C concentrations (mean ± sem). (Fig. 3) . During those periods, progesterone val¬ ues averaged 10.2 ± 1.6 and 0.5 ±0.1 ng/ml, re- Correlation between testosterone and Sm-C in 28 menstruating women. (Copeland et al. 1984) . Therefore modifications in plasma levels of immunoreactive Sm-C do not always necessarily reflect similar variations in bio¬ logic activity.
In conclusion, the present study strongly sug¬ gests that during menstrual cycle in healthy adult women, Sm-C concentrations, while depending mainly on other factors, may be modulated by sex steroids. Pharmacological doses of progestagens increase Sm-C levels. Despite discrepancies in effects of pharmacological doses of oestrogens, it appears that extremely high doses of ethinyloestradiol decrease Sm-C values.
